Novasep has sold its US bio purification subsidiary, TangenX Technology, located in Shrewsbury, Massachusetts, to Repligen, a Waltham, Massachusetts-headquartered bioprocessing-focused life-sciences company, in an all-cash transaction of EUR 37 million ($39 million), which was completed in mid-December 2016.

Novasep acquired a majority stake in TangenX in 2006. TangenX develops, produces, and sells tangential flow filtration technologies.

Source: Novasep